Matches in Wikidata for { <http://www.wikidata.org/entity/Q57624160> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q57624160 description "article published in 2012" @default.
- Q57624160 description "im Jahr 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57624160 description "wetenschappelijk artikel" @default.
- Q57624160 description "наукова стаття, опублікована у 2012" @default.
- Q57624160 name "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 name "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 type Item @default.
- Q57624160 label "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 label "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 prefLabel "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 prefLabel "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 P1433 Q57624160-AAC582FC-A432-450A-945F-A74699144F1D @default.
- Q57624160 P1476 Q57624160-102CC98C-1CCE-4882-9007-8D7641D34327 @default.
- Q57624160 P2093 Q57624160-0FB0B424-1022-4543-AD0E-5CFE8452322D @default.
- Q57624160 P2093 Q57624160-126CA66F-048E-479A-95FB-913F0526B5F4 @default.
- Q57624160 P2093 Q57624160-32EEF3D1-D5E1-48E5-A3C1-F38153960F3F @default.
- Q57624160 P2093 Q57624160-98D82C35-2B3A-40D6-AF68-BB62407366E8 @default.
- Q57624160 P2093 Q57624160-AADF8298-B85A-40A1-A51E-8DBDD8EE33B6 @default.
- Q57624160 P304 Q57624160-B594D66A-5ECF-453D-9756-0E9E54F14C88 @default.
- Q57624160 P31 Q57624160-CF86C51A-0E1D-429B-8098-69FA077F35E6 @default.
- Q57624160 P356 Q57624160-BA87DF73-2B33-47DA-89EE-06EA649CEDEB @default.
- Q57624160 P433 Q57624160-0FCD19E5-4C64-4A1C-ADC4-02D883BC2D10 @default.
- Q57624160 P478 Q57624160-E64C9BEF-B06B-4438-9234-95296814087E @default.
- Q57624160 P50 Q57624160-7542D32A-7D46-4F37-B292-1F0EE26FA3E9 @default.
- Q57624160 P577 Q57624160-B05EC22C-600E-4E87-BD76-942265D8E83A @default.
- Q57624160 P698 Q57624160-61996C8C-E5C8-43DA-B1EB-B74990AD35C3 @default.
- Q57624160 P921 Q57624160-0ED4C28E-0864-4F14-AD56-D923A70DBD00 @default.
- Q57624160 P921 Q57624160-2ED6D4EF-DE7D-4708-9D17-F51DAF6DB4D1 @default.
- Q57624160 P921 Q57624160-54CE8046-0B23-491E-A42B-7B8FB6A5A556 @default.
- Q57624160 P356 TH11-08-0554 @default.
- Q57624160 P698 22234447 @default.
- Q57624160 P1433 Q15724413 @default.
- Q57624160 P1476 "Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome" @default.
- Q57624160 P2093 "Beverley J. Hunt" @default.
- Q57624160 P2093 "Gary W. Moore" @default.
- Q57624160 P2093 "Karen A. Breen" @default.
- Q57624160 P2093 "Kiran Parmar" @default.
- Q57624160 P2093 "Sara E. Stuart-Smith" @default.
- Q57624160 P304 "423-429" @default.
- Q57624160 P31 Q13442814 @default.
- Q57624160 P356 "10.1160/TH11-08-0554" @default.
- Q57624160 P433 "03" @default.
- Q57624160 P478 "107" @default.
- Q57624160 P50 Q37374172 @default.
- Q57624160 P577 "2012-01-01T00:00:00Z" @default.
- Q57624160 P698 "22234447" @default.
- Q57624160 P921 Q582207 @default.
- Q57624160 P921 Q63878006 @default.
- Q57624160 P921 Q79460 @default.